RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Acumen Pharmaceuticals Stock

Acumen Pharmaceuticals P/E 2024

Acumen Pharmaceuticals P/E

-1.65

Ticker

ABOS

ISIN

US00509G2093

As of Sep 13, 2024, Acumen Pharmaceuticals's P/E ratio was -1.65, a -64.44% change from the -4.64 P/E ratio recorded in the previous year.

The Acumen Pharmaceuticals P/E history

Acumen Pharmaceuticals Aktienanalyse

What does Acumen Pharmaceuticals do?

Acumen Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Acumen Pharmaceuticals's P/E Ratio

The Price to Earnings (P/E) Ratio of Acumen Pharmaceuticals is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Acumen Pharmaceuticals's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Acumen Pharmaceuticals is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Acumen Pharmaceuticals’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Acumen Pharmaceuticals stock

What is the price-to-earnings ratio of Acumen Pharmaceuticals?

The price-earnings ratio of Acumen Pharmaceuticals is currently -1.65.

How has the price-earnings ratio of Acumen Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Acumen Pharmaceuticals has increased by -64.44% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Acumen Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Acumen Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Acumen Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Acumen Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Acumen Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Acumen Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Acumen Pharmaceuticals?

Some factors that influence the price-earnings ratio of Acumen Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Acumen Pharmaceuticals pay?

Over the past 12 months, Acumen Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Acumen Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Acumen Pharmaceuticals?

The current dividend yield of Acumen Pharmaceuticals is .

When does Acumen Pharmaceuticals pay dividends?

Acumen Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Acumen Pharmaceuticals?

Acumen Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Acumen Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Acumen Pharmaceuticals located?

Acumen Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Acumen Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Acumen Pharmaceuticals from 9/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Acumen Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Acumen Pharmaceuticals in the year 2023?

In the year 2023, Acumen Pharmaceuticals distributed 0 USD as dividends.

In which currency does Acumen Pharmaceuticals pay out the dividend?

The dividends of Acumen Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Acumen Pharmaceuticals

Our stock analysis for Acumen Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acumen Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.